A SARS Antigen test using advanced immunofluorescence-based lateral flow technology in a for qualitative detection of nucleocapsid protein from SARS-CoV-2. Our SARS Antigen provides automated and objective results in as little as 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments.